221 related articles for article (PubMed ID: 10229837)
1. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
3. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
4. Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.
Sieweke MH; Tekotte H; Jarosch U; Graf T
EMBO J; 1998 Mar; 17(6):1728-39. PubMed ID: 9501094
[TBL] [Abstract][Full Text] [Related]
5. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
6. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
[TBL] [Abstract][Full Text] [Related]
7. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
8. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
9. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
Kiermaier A; Gawn JM; Desbarats L; Saffrich R; Ansorge W; Farrell PJ; Eilers M; Packham G
Oncogene; 1999 Dec; 18(51):7200-11. PubMed ID: 10602473
[TBL] [Abstract][Full Text] [Related]
10. Direct role for Myc in transcription initiation mediated by interactions with TFII-I.
Roy AL; Carruthers C; Gutjahr T; Roeder RG
Nature; 1993 Sep; 365(6444):359-61. PubMed ID: 8377829
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.
Hasegawa A; Yasukawa M; Sakai I; Fujita S
J Immunol; 2001 Jan; 166(2):1125-31. PubMed ID: 11145693
[TBL] [Abstract][Full Text] [Related]
12. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
13. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
15. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
16. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
Tobias KE; Shor J; Kahana C
Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
[TBL] [Abstract][Full Text] [Related]
17. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
18. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry.
Moriuchi M; Moriuchi H; Turner W; Fauci AS
J Immunol; 1997 Nov; 159(9):4322-9. PubMed ID: 9379028
[TBL] [Abstract][Full Text] [Related]
19. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
20. Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.
White LA; Bruzdzinski C; Kutz SM; Gelehrter TD; Higgins PJ
Exp Cell Res; 2000 Oct; 260(1):127-35. PubMed ID: 11010817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
